OPEN ACCESS: BENEFITS

Benefits to researchers, institutions, nations & Society as whole. For researchers, increased visibility raising impact factor. Benefit for researchers who cant pay for paper subscription. As in todays era of internet its free to access research articles on related latest researches to researchers & Scholars.

CHEMOTHERAPY: OPEN ACCESS

ISSN:2167-7700

Chemotherapy deals with the study & treatment of diseases using chemical agents/drugs, that are selectively toxic to the causative agent of the disease.

Make the research work freely accessible globally through internet to share the innovations of the researchers to scientific community. Chemotherapy aims to provide current events, advantages and limitations in the field of chemotherapy.

Chemotherapy: Open Access consists of 43 well qualified EB members throughout the world mostly from USA, Japan, UK and some other countries

EB MEMBER CATEGORISATION

JOURNAL STATUS
Started

in 2011 Released first issue in March 2012 Recently Released Vol. 2, Issue 3 Releasing Vol 3, Issue 1 in Feb 2013

JOURNAL STATUS

FUNDING ARTICLES

1 article funded by Japan Society for the Promotion of Science and Smoking Research Foundation.
Above 90% from high income country

Journal of Cancer Science & Therapy Journal of Carcinogenesis & Mutagenesis

JCST started in 2009, Currently Vol 5, Issue 2 JCM started in 2010, Currently Vol. 3,Issue 2

RELATED JOURNALS FROM OTHER SOURCE

Journal of Chemotherapy (Maney Publishing) Journal of Infection and Chemotherapy (Springer) Journal of chemotherapy (ResearchGate) Journal of Antimicrobial Chemotherapy (Oxford Journals) International Journal Of Experimental & Clinical Chemotherapy (Karger)

Two Special Issues has been approved for Chemotherapy Translational Pathology Immunochemotherapy

RELATED CONFERENCES
Optimizing Outcomes in Colorectal Cancer Boston, United States of America, 7th Feb 2013. CHI's Targeting Cancer Stem Cells San Francisco, United States of America, 11th Feb 2013. 16thScripps Cancer Center's 33rd Annual Clinical Hematology and Oncology Conference San Diego, United States of America, 16th Feb 2013. 2nd Novel Cancer Therapeutics Summit Las Vegas, United States of America, 25th Feb 2013. 24th Annual Cancer Progress Conference New

7th Conference on Experimental and Translational Oncology CETO Portoroz, Slovenia, 20th April 2013. British Gynaecological Cancer Society Annual Scientific Meeting Belfast , Ireland, 20th June 2013. MASCC/ISOO 2013 International Cancer Care Symposium Berlin, Germany, 27th June 2013. 27th17th ECCO - 38th ESMO - 32nd ESTRO European Cancer

th

TO ADVERTISE THE JOURNAL AT CONFERENCES

Firstly advertise on the conference website by placing banner

ads with a link to our website. At the conference venue placing our banners Make use of pamphlets, Journal Digital file to explain about our journals scope. Inviting researchers attending related conference by invitation letter and pamphlets

INDEXING

It shows our table of content and abstracts included in various online collections. It increases visibility of our journal & perceived quality of our journal.

It increases the ability to be searched for information among various other publications.

INDEXING OF THE JOURNAL

Chemotherapy is indexed in Google Scholar OARE Open J-Gate DOAJ COPERNICUS SCRIUS

PLAN FOR INDEXING IN SCOPUS,MEDLINE,ISI

Issue release at regular interval. Send invitations to quality person having relevant field of interest as per the journal. Coin special issue topics on recent ongoing researches. Updates EB profile every month based on their designation, research interest etc. Provide variable fee for different countries.

Gentle and polite communication in a professional way with the researchers. Form your own words at different situations or for replies instead of same type of communication to gain interest from contributors. Regular communication with EB members and researchers for their suggestions and contributors.

Updating status of EB member in website regarding their designation, research interest and ongoing projects, thus by communicating regularly to gain interest from them. Accepting quality paper regardless of country. Providing variable fee for different countries.

CONTACT US
Articles can be submitted to editor.cmt@omicsonline.org or http://omicsgroup.org/editorialtracking/chemother apy/SubmitManuscript.php Website: http://www.omicsgroup.org/journals/cmthome.php